Effects of a Low-FODMAP Diet on Irritable Bowel Syndrome in Both Children and Adults-A Narrative Review.
Study Goal
The researchers aimed to evaluate the efficacy of a low-FODMAP diet compared to other diets in reducing gastrointestinal symptoms, assessing nutrient intake, and improving quality of life in adults and children with irritable bowel syndrome.
Results Summary
The study found significant evidence that a low-FODMAP diet may effectively reduce stomach discomfort, pain, bloating, and improve quality of life for irritable bowel syndrome patients. The diet was compared against other dietary strategies, showing favorable outcomes.
Population
Adults and children with irritable bowel syndrome.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) | decrease | abdominal symptoms | patients with irritable bowel syndrome | - | is one of the potential treatment strategies to reduce | #1 |
a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) | increase | quality of life | patients with irritable bowel syndrome | - | is one of the potential treatment strategies to increase | #2 |
a low-FODMAP diet | decrease | stomach discomfort | patients with irritable bowel syndrome | - | might be a feasible first-line therapeutic strategy to reduce | #3 |
a low-FODMAP diet | decrease | pain | patients with irritable bowel syndrome | - | might be a feasible first-line therapeutic strategy to reduce | #4 |
a low-FODMAP diet | decrease | bloating | patients with irritable bowel syndrome | - | might be a feasible first-line therapeutic strategy to reduce | #5 |
a low-FODMAP diet | increase | quality of life | patients with irritable bowel syndrome | - | might be a feasible first-line therapeutic strategy to improve | #6 |
Irritable bowel syndrome is a typical gastrointestinal disease that causes bloating, flatulence, abdominal pain, diarrhoea, constipation, or alteration of the last two in adults and children. A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) is one of the potential treatment strategies to reduce abdominal symptoms and increase the quality of life. The present narrative review aims to present a general overview of current studies that have evaluated the efficacy of a low-FODMAP diet against other diets in gastrointestinal symptoms, nutrient intake in adults and children, and lifestyle quality. The research was performed using seven searchable databases, which included the Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews (CDSR), Excerpta Medica Database (EMBASE), Medline, PubMed, Scopus, and Web of Science, up to March 2023. In conclusion, there is significant evidence that the follow-up of a low-FODMAP diet might be a feasible first-line therapeutic strategy to reduce stomach discomfort, pain, bloating, and quality of life for patients with irritable bowel syndrome.